Threshold Pharmaceuticals, Inc. Stock Nasdaq
Equities
US8858072064
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 12.7M | Sales 2025 * | 1.37M | Capitalization | 9.74M |
---|---|---|---|---|---|
Net income 2024 * | -22M | Net income 2025 * | -34M | EV / Sales 2024 * | 0.77 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 7.13 x |
P/E ratio 2024 * |
-0.46
x | P/E ratio 2025 * |
-0.38
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.04% |
Managers | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 99-12-31 |
Jason Kim
PSD | President | 49 | 09-12-31 |
Kristen Quigley
COO | Chief Operating Officer | 53 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Eric Poma
CEO | Chief Executive Officer | 52 | 99-12-31 |
Harold Selick
CHM | Chairman | 69 | 17-07-31 |
David Hoffmann
BRD | Director/Board Member | 79 | 17-07-31 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |